NCT06641765View on ClinicalTrials.gov

Continuous Glucose Monitoring in Dialysis Patients With Diabetes

NARecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Continuous Glucose MonitoringHaemodialysisPeritoneal Dialysis
Interventions
DEVICE

Continous Glucose Monitoring

10 days of real time open access to Continous Glucose Monitoring - either at defined time intervals (Group 2) or continuously for 9 months (Group 3).

Trial Locations (5)

2100

RECRUITING

Rigshospitalet, Copenhagen

2730

NOT_YET_RECRUITING

Herlev Hospital, Herlev

3400

NOT_YET_RECRUITING

North Zealand Hospital, Hillerød, Hillerød

4000

NOT_YET_RECRUITING

Zealand University Hospital, Roskilde

4300

NOT_YET_RECRUITING

Holbæk Sygehus, Holbæk

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

Bo Feldt-Rasmussen

OTHER

NCT06641765 - Continuous Glucose Monitoring in Dialysis Patients With Diabetes | Biotech Hunter | Biotech Hunter